STAT3 in cancer: A double edged sword

Lidia Avalle1, Annalisa Camporeale1, Andrea Camperi1

  • 1Molecular Biotechnology Center, Department of Molecular Biotechnology and Life Sciences, University of Turin, Via Nizza 52, 10126 Turin, Italy.

Cytokine
|June 6, 2017
PubMed

Insights

Signal transducer and activator of transcription (STAT) 3 is a key factor in cell functions. Its dual role as oncogene or tumor suppressor depends on complex modifications and cellular context.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Oncology

Background:

  • Signal transducer and activator of transcription (STAT) 3 is activated by cytokines, growth factors, and oncogenes.
  • Aberrant STAT3 activity is prevalent in various tumors, promoting cancer progression.
  • STAT3 is considered an oncogene and is a focus of translational research.

Purpose of the Study:

  • To explore the heterogeneous functions of STAT3 in different cellular contexts.
  • To elucidate the molecular mechanisms underlying STAT3's contrasting roles.
  • To discuss factors influencing STAT3's pro-oncogenic or tumor-suppressive activities.

Main Methods:

  • Review of existing literature on STAT3.
  • Analysis of post-translational modifications of STAT3.
  • Investigation of STAT3's interaction with cell metabolism.
  • Examination of STAT3's role in tumor and microenvironment cells.

Main Results:

  • STAT3 exhibits context-dependent functions, acting as either a pro-oncogene or tumor suppressor.
  • Post-translational modifications significantly influence STAT3's localization and activity.
  • STAT3 activity is intricately linked with cellular metabolic states.
  • STAT3 controls the behavior of both tumor cells and their microenvironment.

Conclusions:

  • The complex functions of STAT3 are shaped by post-translational modifications, cellular metabolism, and microenvironment interactions.
  • Understanding these regulatory mechanisms is crucial for deciphering STAT3's role in cancer.
  • Further research is needed to fully comprehend STAT3's dualistic behavior in tumorigenesis.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.2K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.1K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K